A61K 38/1783
Nuclear receptors
Official title: {Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors}
A61K38/1783 (Nuclear receptors) appears on 9 US grants and 38 published applications in this corpus.
Search patents in A61K- Granted patents
- 9
- Published applications
- 38
- Assignees
- 23
- Inventors
- 83
- Latest grant
- 3 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 4 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 2 |
| 2017 | 1 | 1 |
| 2018 | 2 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 5 |
| 2022 | 2 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 2 |
| 2025 | 0 | 2 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating microbial inflammation3 Oct 2023US 11,771,739 B2The United States AS Represented By the Department of Veterans Affairs
- Methods for modulating development and function of photoreceptor cells7 Jun 2022US 11,351,225 B2The Schepens Eye Research Institute, Inc.
- Recombinant thrombomodulin domain 1 for use in treating eye diseases associated with pathological ocular angiogenesis24 May 2022US 11,338,019 B2
- Monocyte modulation and control of tumor metastasis6 Jul 2021US 11,053,297 B2La Jolla Institute for Allergy and Immunology
- Therapeutic effects of NURR1 and FOXA2 in inflammatory neurologic disorders by M1-to-M2 polarization of glial cells11 Feb 2020US 10,555,972 B2Innopeutics Corporation
- Transcriptional therapy based-lipid nanoparticles and mrna for the treatment of end-stage liver disease27 Aug 2026US 2026/0250351 A1The Trustees of the University of Pennsylvania
- Compositions and methods of treating, preventing, or delaying the progression of neurodegenerative disease25 Jun 2026US 2026/0174908 A1Arizona Board of Regents on Behalf of the University of Arizona
- Adeno-associated virus vectors for nucleic acid delivery across retinal regions10 Jul 2025US 2025/0222135 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Adeno-associated virus vectors for nucleic acid delivery to retinal ganglion cells and/or retinal pigment epithelium cells3 Jul 2025US 2025/0213722 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Compositions and methods for modulating molecules5 Dec 2024US 2024/0400642 A1Etern Therapeutics Inc.
Most cited
By later US patents
- Therapeutic effects of NURR1 and FOXA2 in inflammatory neurologic disorders by M1-to-M2 polarization of glial cells1US 10,555,972 B2Innopeutics Corporation · 2020
- Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor1US 9,827,216 B2Institut Curie · 2017
- Methods for modulating development and function of photoreceptor cells1US 9,855,314 B2The Schepens Eye Research Insititute, Inc. · 2018